Panic seems to driving the market: oil prices plummeted, equities took a hit, and the S&P 500 lost about 5%. Be on the lookout for, inter alia, the European Central Bank’s policy decision on Thursday and the release of the U.S. core consumer price index on Wednesday. – Bloomberg and NYT

Big Tech companies using facial recognition software have begun to support “’precision regulations’ that don’t allow mass surveillance.” Lawmakers in New York, Massachusetts, Hawaii, Michigan, and California are considering regulations that concern some form of the technology’s use. – WSJ

Somebody is probably watching. Facial recognition startups have seen success, perfecting their craft more than you care to know. – NYT

Boeing Co.’s 737 MAX continues to suffer delays; regulators at the FAA will likely order Boeing to reroute the wiring that, under extreme circumstances, could fail and cost more lives. – WSJ

Insurance brokerages, Aon Plc and Willis Towers Watson Plc., combine after Aon agreed to buy Willis Towers for $30 billion. According to the companies, the deal “will add to earnings in the first full year of the combination, and provide annual pretax synergies and cost reductions of about $800 million by the third year. “ – Bloomberg

Elbow bumping is too close to keep the coronavirus at bay. The WHO director said so in a tweet on Saturday—recommending individuals keep 2 feet of social distance, frequently wash their hands, and resist the urge to often touch one’s face. – Bloomberg

Hey, Doc! New federal regulations will make it easier for patients to have access to their data on apps and web portals, however, the regulations may also cost patients their privacy. How do you feel now that Big Tech may soon have your medical record? – WSJ

Batter up! Compass Diversified Holdings agreed to buy Marucci Sports LLC, the top baseball bat manufacturer, for $200 million. – WSJ

The life of the coronavirus in a nutshell. For most infected, the virus causes little more than a cough if it stays in the nose and throat. However, one in seven patients develops difficulty breathing and other severe complications, with 6% of these individuals becoming critical. Once in the lungs and respiratory tract the virus causes pneumonia-like damage and compromises the body’s ability to keep germs out of the lungs. This second effect makes the virus particularly difficult to treat, given the significant amount of germs found at hospitals. – Bloomberg

Time for some wine talk, with a side of cheese. Here are some recommendations I will have ready next time I have guests. – WSJ